Worth reading
84Important
Scored from 4 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
143
¥100 millionWording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportFirst quarter of the fiscal year ending March 202710 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥481 100 million+42.5%
Operating profit¥22 100 million+113.4%
Ordinary income¥22 100 million+153.6%
Net income¥34 100 million+560.5%
Operating profit margin4.8%, up 1.6 percentage points year on year
Selling, general and administrative expensesSelling, general and administrative expenses in the Chemical Business: up ¥16 million. Group-wide SG&A expenses and the SG&A-to-revenue ratio were not disclosed.
Results for the three months of the current quarterRevenue of ¥48.1 billion, operating profit of ¥2.2 billion, ordinary profit of ¥2.2 billion, and profit attributable to owners of the parent of ¥3.4 billion
Full-year earnings forecast
Net Sales
¥1,946 100 million
Operating profit
¥65 100 million
Ordinary income
¥56 100 million
Profit attributable to owners of the parent
¥54 100 million
Dividend per share
¥125
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Japan, North America and Asia were broadly in line with plan; China was 44% below plan. Consolidated results were 5% below plan.Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Consolidated operating profitReNova business: +¥507 million; Resin-Processed Products Business: +¥804 million; Chemical Business: +¥442 million; Other: -¥26 million
Resin-Processed Products Business operating profitReNova business: +¥507 million; production fluctuations: +¥55 million; impact of mold-related profit: +¥123 million; inflation: -¥92 million; cost improvements: +¥131 million; other: +¥81 million
Chemical Business operating profitChanges in sales: +¥146 million; changes in gross profit: +¥280 million; changes in SG&A expenses: +¥16 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Foreign Exchange
US dollars¥145.0 per US dollar
Chinese yuan¥19.5 per Chinese yuan
New initiatives
Integration of the technology, products, customer base, personnel and expertise acquired through the acquisition and consolidation of the ReNova business. The domestic motorcycle resin parts business changed from the Chemical Business to the Resin-Processed Products Business.Key KPIsA metric the company considers important as a management benchmark.
Regional production: consolidated +25%, Japan +124%, North America +6%, China -50%, Asia +68% (existing businesses only: consolidated -7%, Japan +12%, North America -14%, Asia -14%). ReNova business revenue was ¥12.9 billion, operating profit was ¥500 million, and the operating margin was 3.9%.Unit price and quantity metricsThese figures show sales broken down by price and volume.
The materials indicate an increase in Chemical Business sales volumes and the effects of price revisions, but specific figures for volumes and unit prices were not disclosed.Segment results
Resin-Processed Products Business
Net Sales
¥416 100 million+50.5%
Operating profit
¥20 100 million+65.1%
Chemicals Business
Net Sales
¥64 100 million+6.3%
Operating profit
¥7 100 million+157.1%
Medium-term management plan targets
The materials refer to contributions to the development themes of the 14th Medium-Term Management Plan. Specific targets and target years were not disclosed.Financial targets
Equity ratio: 40.2% (actual at the end of Q1 FY2027). The target was not disclosed.Annual Dividend
Annual dividend of ¥125.0 per share (the interim and year-end breakdown was not disclosed)| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥481 100 million (YoY +42.5%) |
| Operating profit | ¥22 100 million (YoY +113.4%) |
| Ordinary income | ¥22 100 million (YoY +153.6%) |
| Net income | ¥34 100 million (YoY +560.5%) |
| Operating profit margin | 4.8%, up 1.6 percentage points year on year |
| Selling, general and administrative expenses | Selling, general and administrative expenses in the Chemical Business: up ¥16 million. Group-wide SG&A expenses and the SG&A-to-revenue ratio were not disclosed. |
| Results for the three months of the current quarter | Revenue of ¥48.1 billion, operating profit of ¥2.2 billion, ordinary profit of ¥2.2 billion, and profit attributable to owners of the parent of ¥3.4 billion |
| Full-year earnings forecast | Net Sales ¥1,946 100 million / Operating profit ¥65 100 million / Ordinary income ¥56 100 million / Profit attributable to owners of the parent ¥54 100 million / Dividend per share ¥125 |
| Self-assessment against the plan | Japan, North America and Asia were broadly in line with plan; China was 44% below plan. Consolidated results were 5% below plan. |
| Segment results | Resin-Processed Products Business Net Sales ¥416 100 million (YoY +50.5%) / Operating profit ¥20 100 million (YoY +65.1%) / Chemicals Business Net Sales ¥64 100 million (YoY +6.3%) / Operating profit ¥7 100 million (YoY +157.1%) |
| Breakdown of Factors Affecting the Change | Consolidated operating profit ReNova business: +¥507 million; Resin-Processed Products Business: +¥804 million; Chemical Business: +¥442 million; Other: -¥26 million / Resin-Processed Products Business operating profit ReNova business: +¥507 million; production fluctuations: +¥55 million; impact of mold-related profit: +¥123 million; inflation: -¥92 million; cost improvements: +¥131 million; other: +¥81 million / Chemical Business operating profit Changes in sales: +¥146 million; changes in gross profit: +¥280 million; changes in SG&A expenses: +¥16 million |
| Key KPIs | Regional production: consolidated +25%, Japan +124%, North America +6%, China -50%, Asia +68% (existing businesses only: consolidated -7%, Japan +12%, North America -14%, Asia -14%). ReNova business revenue was ¥12.9 billion, operating profit was ¥500 million, and the operating margin was 3.9%. |
| Unit price and quantity metrics | The materials indicate an increase in Chemical Business sales volumes and the effects of price revisions, but specific figures for volumes and unit prices were not disclosed. |
| Assumptions Underlying the Business Outlook | Foreign Exchange US dollars ¥145.0 per US dollar / Chinese yuan ¥19.5 per Chinese yuan |
| Medium-term management plan targets | The materials refer to contributions to the development themes of the 14th Medium-Term Management Plan. Specific targets and target years were not disclosed. |
| Financial targets | Equity ratio: 40.2% (actual at the end of Q1 FY2027). The target was not disclosed. |
| Annual Dividend | Annual dividend of ¥125.0 per share (the interim and year-end breakdown was not disclosed) |
| New initiatives | Integration of the technology, products, customer base, personnel and expertise acquired through the acquisition and consolidation of the ReNova business. The domestic motorcycle resin parts business changed from the Chemical Business to the Resin-Processed Products Business. |
Items this document does not state (11)
Gross Profit MarginProgress against full-year forecastNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue and profit increased in Q1, reflecting the consolidation of the ReNova business, solid performance in the existing businesses in Japan and North America, higher chemical business sales and the effects of price revisions, and foreign exchange movements. Net profit increased because a ¥2.1 billion gain on negative goodwill arising from the consolidation of the ReNova business was recorded as extraordinary income. The full-year forecasts were revised upward to reflect the Q1 outperformance and the gain on negative goodwill.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.